Bicycle Therapeutics PLC
BCYC· Nasdaq
Released Aug 8, 2025, before the open
10-Q filed Aug 8, 2025, 39 days after period end · 0001558370-25-010843
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $2.92M | $9.36M | $11.40M | $4.38M |
| Net Income | -$78.95M | -$39.81M | -$42.60M | -$26.83M |
| EPS Diluted |
Bicycle Therapeutics PLC · CIK 1761612 · Engraved from SEC EDGAR
| -$1.14 |
| -$0.77 |
| -$1.41 |
| -$0.90 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.